Who owns TITAN PHARMACEUTICALS INC DEL?

Tip: Access positions for across all investors

Analyze quarterly positions in Titan Pharmaceuticals Inc Del with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Titan Pharmaceuticals Inc Del stock

Who bought or sold TITAN PHARMACEUTICALS INC DEL this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
DRW Holdings 21k $102k 100% Sep 2025
 View chart
UBS Group 480.00 $2.4k -86% Sep 2025
 View chart
Tower Research Capital 469.00 $2.2k 100% Sep 2025
 View chart
CoreCap Advisors 88.00 $422.004000 0% Sep 2025
 View chart
Group One Trading 12.00 $57.999600 0% Sep 2025
 View chart
Advisor Group Holdings 10.00 $35.000000 0% Sep 2025
 View chart
BlackRock 6.00 $28.999800 0% Sep 2025
 View chart
Morgan Stanley 2.00 $8.000000 100% Jun 2025
 View chart
Global Wealth Strategies & Associates 2.00 $10.000000 0% Sep 2025
 View chart
Caldwell Sutter Capital 1.00 $5.000000 0% Sep 2025
 View chart
Ransom Advisory 1.00 $5.000000 0% Sep 2025
 View chart
D. J. St. Germain 1.00 $5.000000 0% Sep 2025
 View chart
CWM 1.00 $0 100% Sep 2025
 View chart
SBI Securities 1.00 $5.000000 0% Sep 2025
 View chart
Westside Investment Management 1.00 $5.000000 0% Sep 2025
 View chart
Wells Fargo & Company 1.00 $5.000000 0% Sep 2025
 View chart
Cape Investment Advisory 1.00 $4.000000 0% Jun 2025
 View chart
Nemes Rush Group 1.00 $5.000000 0% Sep 2025
 View chart

Who sold out of Titan Pharmaceuticals Inc Del?

Fund or Company Name Date Sold Shares Held Valued At
Citadel Advisors Jun 2025 12k $51k
Renaissance Technologies Jun 2025 11k $48k
Marex Group Jun 2025 11k $45k
Raymond James Financial Jun 2025 1.00 $4.000000